Literature DB >> 11379458

Prostate specific antigen in the Nigerian African.

F M Abbiyesuku1, O B Shittu, O O Oduwole, B O Osotimehin.   

Abstract

The biological characteristics of prostate-specific antigen were studied in the Nigerian African. Two hundred and fourteen persons were selected for the study. The group was made up of 59 apparently healthy men (age range 22-76 years), 58 men (age range 40-91 years) who had biopsy proven diagnosis of cancer of the prostate gland, 81 men (age range 46-87 years) who had biopsy proven benign prostatic hypertrophy (BPH) and 16 women (age range 23-47 years). Their median ages were 53 years, 66 years, 66 years and 27 years, respectively. The median PSA value among the control population was 0.7 ug/L (range 0.1-4.3 ug/L) and 98.3% of them had PSA of less than 4 ug/L. No person below 50 years of age had PSA value greater than 2 ug/L. There was a significant correlation between age and serum PSA value over the entire age range (r = 0.523; P = 0.001). In the female study group, 4(25%) had detectable values the cause of which could not be determined. The median PSA value among the BPH patients was 8.5 ug/L (range 0.2-350 ug/L). In this group 37% of them had values below 4 ug/L and 54.3% of them had values less than 10 ug/L. Among the patients who had cancer of the prostate gland the median PSA value was 92.6 ug/L and the mode was greater than 350 ug/L (32% of the patients); 10% and 20% of them had values below 4 ug/L and 10 ug/L respectively. It is concluded that the trend is the same as in the studies and there is the need for prostate gland volume studies and evaluation of women who have detectable PSA values.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11379458

Source DB:  PubMed          Journal:  Afr J Med Med Sci        ISSN: 0309-3913


  7 in total

1.  Analysis of Gleason grade and scores in 90 Nigerian Africans with prostate cancer during the period 1994 to 2004.

Authors:  U G Ugare; I E Bassey; P G Jibrin; I A Ekanem
Journal:  Afr Health Sci       Date:  2012-03       Impact factor: 0.927

2.  Review of prostate cancer research in Nigeria.

Authors:  Titilola O Akinremi; Chidiebere N Ogo; Ayodeji O Olutunde
Journal:  Infect Agent Cancer       Date:  2011-09-23       Impact factor: 2.965

3.  Prevalence and characteristics of prostate cancer among participants of a community-based screening in Nigeria using serum prostate specific antigen and digital rectal examination.

Authors:  Stephen Odunayo Ikuerowo; Olufunmilade Adefolarin Omisanjo; Muftau Jimoh Bioku; Michael Olawale Ajala; Victor Patrick Nonyelim Mordi; Julius Olusanmi Esho
Journal:  Pan Afr Med J       Date:  2013-08-10

4.  Serum total prostate-specific antigen values in men with symptomatic prostate enlargement in Nigeria: role in clinical decision-making.

Authors:  Ikenna I Nnabugwu; Fred O Ugwumba; Oghenekaro A Enivwenae; Emeka I Udeh; Chris O Otene; Chinwe A Nnabugwu
Journal:  Clin Interv Aging       Date:  2014-12-30       Impact factor: 4.458

5.  Age-specific Serum Prostate Specific Antigen Ranges Among Apparently Healthy Nigerian Men Without Clinical Evidence of Prostate Cancer.

Authors:  S O Ikuerowo; M O Ajala; A A Abolarinwa; O A Omisanjo
Journal:  Niger J Surg       Date:  2016 Jan-Jun

6.  Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of african descent.

Authors:  Timothy R Rebbeck; Susan S Devesa; Bao-Li Chang; Clareann H Bunker; Iona Cheng; Kathleen Cooney; Rosalind Eeles; Pedro Fernandez; Veda N Giri; Serigne M Gueye; Christopher A Haiman; Brian E Henderson; Chris F Heyns; Jennifer J Hu; Sue Ann Ingles; William Isaacs; Mohamed Jalloh; Esther M John; Adam S Kibel; Lacreis R Kidd; Penelope Layne; Robin J Leach; Christine Neslund-Dudas; Michael N Okobia; Elaine A Ostrander; Jong Y Park; Alan L Patrick; Catherine M Phelan; Camille Ragin; Robin A Roberts; Benjamin A Rybicki; Janet L Stanford; Sara Strom; Ian M Thompson; John Witte; Jianfeng Xu; Edward Yeboah; Ann W Hsing; Charnita M Zeigler-Johnson
Journal:  Prostate Cancer       Date:  2013-02-13

7.  The value of percentage free prostate specific antigen (PSA) in the detection of prostate cancer among patients with intermediate levels of total PSA (4.0-10.0 ng/mL) in Nigeria.

Authors:  E V Ezenwa; K H Tijani; E A Jeje; O O Soriyan; M A Ogunjimi; R W Ojewola; O I Ajie; A R El-Nahas
Journal:  Arab J Urol       Date:  2012-07-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.